Safety perspectives on presently considered drugs for the treatment of COVID-19. (2020)

First Author: Penman SL
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.15204

PubMed Identifier: 32681537

Publication URI: http://europepmc.org/abstract/MED/32681537

Type: Journal Article/Review

Volume: 177

Parent Publication: British journal of pharmacology

Issue: 19

ISSN: 0007-1188